These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 28452989)
1. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. Labetoulle M; Chiambaretta F; Shirlaw A; Leaback R; Baudouin C Eye (Lond); 2017 Oct; 31(10):1409-1416. PubMed ID: 28452989 [TBL] [Abstract][Full Text] [Related]
2. Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease. Baudouin C; Cochener B; Pisella PJ; Girard B; Pouliquen P; Cooper H; Creuzot-Garcher C Eur J Ophthalmol; 2012; 22(5):751-61. PubMed ID: 22287172 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study. Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Brignole F; Pisella PJ; Dupas B; Baeyens V; Baudouin C Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):531-8. PubMed ID: 15965673 [TBL] [Abstract][Full Text] [Related]
5. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. Mencucci R; Boccalini C; Caputo R; Favuzza E J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Lee JH; Ahn HS; Kim EK; Kim TI Cornea; 2011 Feb; 30(2):175-9. PubMed ID: 21045674 [TBL] [Abstract][Full Text] [Related]
7. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Park DH; Chung JK; Seo DR; Lee SJ Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791 [TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome. Chiambaretta F; Doan S; Labetoulle M; Rocher N; Fekih LE; Messaoud R; Khairallah M; Baudouin C; Eur J Ophthalmol; 2017 Jan; 27(1):1-9. PubMed ID: 27445067 [TBL] [Abstract][Full Text] [Related]
9. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye. Barabino S; Rolando M; Nardi M; Bonini S; Aragona P; Traverso CE Eur J Ophthalmol; 2014; 24(2):173-8. PubMed ID: 24030535 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye. Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831 [TBL] [Abstract][Full Text] [Related]
11. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N; Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study. Yao K; Bao Y; Ye J; Lu Y; Bi H; Tang X; Zhao Y; Zhang J; Yang J BMC Ophthalmol; 2015 Mar; 15():28. PubMed ID: 25880685 [TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study. Aragona P; Benítez-Del-Castillo JM; Coroneo MT; Mukherji S; Tan J; Vandewalle E; Vingrys A; Liu H; Carlisle-Wilcox C; Vehige J; Simmons PA Clin Ophthalmol; 2020; 14():2951-2963. PubMed ID: 33061281 [TBL] [Abstract][Full Text] [Related]
14. Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA). El Fekih L; Khairallah M; Ben Amor H; Mahmoud A; Chiambaretta F; Messaoud R J Fr Ophtalmol; 2024 Sep; 47(7):104169. PubMed ID: 38838456 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye. Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755 [TBL] [Abstract][Full Text] [Related]
16. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Benelli U; Nardi M; Posarelli C; Albert TG Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS; Ji YS; Yoon KC Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model. She Y; Li J; Xiao B; Lu H; Liu H; Simmons PA; Vehige JG; Chen W J Ocul Pharmacol Ther; 2015 Nov; 31(9):525-30. PubMed ID: 26322539 [TBL] [Abstract][Full Text] [Related]
19. Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial. Laihia J; Järvinen R; Wylęgała E; Kaarniranta K Acta Ophthalmol; 2020 May; 98(3):244-254. PubMed ID: 31579987 [TBL] [Abstract][Full Text] [Related]
20. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye. Park Y; Song JS; Choi CY; Yoon KC; Lee HK; Kim HS J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]